Circumferential and Focal Ablation of Barrett's Esophagus Containing Dysplasia
暂无分享,去创建一个
Ananya Das | D. Fleischer | V. Sharma | H. J. Kim | C. Nguyen | C. Wells | C. D. Wells
[1] Kenneth J. Chang,et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. , 2008, Gastrointestinal endoscopy.
[2] D. Fleischer,et al. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). , 2008, Endoscopy.
[3] N. Shaheen,et al. Our new president--Robert S. Sandler, MD, MPH. , 2008, Gastroenterology.
[4] Kenneth J. Chang,et al. 213 A Randomized, Multicenter, Sham-Controlled Trial of Radiofrequency Ablation (RFA) for Subjects with Barrett's Esophagus (Be) Containing Dysplasia: Interim Results of the Aim Dysplasia Trial , 2008 .
[5] P. Fockens,et al. Effective treatment of early Barrett’s neoplasia with stepwise circumferential and focal ablation using the HALO system , 2008, Endoscopy.
[6] C. D. Smith,et al. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system , 2007, Surgical Endoscopy.
[7] Bergein F Overholt,et al. Photodynamic therapy with porfimer sodium for ablation of high-grade dysplasia in Barrett's esophagus: international, partially blinded, randomized phase III trial. , 2005, Gastrointestinal endoscopy.
[8] P. Shekelle,et al. Dysplasia and Risk of Further Neoplastic Progression in a Regional Veterans Administration Barrett's Cohort , 2005, The American Journal of Gastroenterology.
[9] S. Spechler,et al. Dysplasia in Barrett's Esophagus: Limitations of Current Management Strategies , 2005, The American Journal of Gastroenterology.
[10] N. Shaheen,et al. Effect of a New Diagnosis of Barrett's Esophagus on Insurance Status , 2005, The American Journal of Gastroenterology.
[11] A. Ippoliti,et al. Randomized trial of argon plasma coagulation vs. multipolar electrocoagulation for ablation of Barrett's esophagus. , 2005, Gastrointestinal endoscopy.
[12] K. Batts,et al. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: a phased evaluation in the porcine and in the human esophagus. , 2004, Gastrointestinal endoscopy.
[13] K. Griffith,et al. Dysplasia in Barrett esophagus , 2004 .
[14] R. Cestari,et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. incidence of dysplasia and adenocarcinoma: a prospective study , 2003, American Journal of Gastroenterology.
[15] D. Faigel,et al. Risk Factors for Dysplasia in Patients with Barrett's Esophagus (BE): Results from a Multicenter Consortium , 2003, Digestive Diseases and Sciences.
[16] T. Smyrk,et al. Small adenocarcinomas of the esophagogastric junction: association with intestinal metaplasia and dysplasia , 2002, American Journal of Gastroenterology.
[17] S. Spechler,et al. Clinical practice. Barrett's Esophagus. , 2002, The New England journal of medicine.
[18] P. Pronovost,et al. Hospital volume is related to clinical and economic outcomes of esophageal resection in Maryland. , 2001, The Annals of thoracic surgery.
[19] C. Gutschow,et al. Demographic variations in the rising incidence of esophageal adenocarcinoma in white males , 2001, Cancer.
[20] A. Sonnenberg,et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. , 2001, Gastroenterology.
[21] Prateek Sharma,et al. p53 protein overexpression in low grade dysplasia (LGD) in barrett's esophagus: Immunohistochemical marker predictive of progression , 2001, American Journal of Gastroenterology.
[22] E. Montgomery,et al. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study. , 2001, Human pathology.
[23] J K Greenson,et al. Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation. , 2001, Human pathology.
[24] J. Goldblum,et al. The diagnosis of low-grade dysplasia in Barrett's esophagus and its implications for disease progression , 2000, American Journal of Gastroenterology.
[25] J. Goldblum,et al. Original contributionThe diagnosis of low-grade dysplasia in Barrett’s esophagus and its implications for disease progression , 2000 .
[26] R. Playford,et al. Final results from 10 year cohort of patients undergoing surveillance for Barrett's oesophagus: observational study , 2000, BMJ : British Medical Journal.
[27] Gary Longton,et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets , 2000, American Journal of Gastroenterology.
[28] Patricia L. Blount,et al. Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low- and high-risk patient subsets. , 2000 .
[29] A. Lindgren,et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. , 1999, The New England journal of medicine.
[30] W. Richardson,et al. Esophageal resection for cancer. , 1998, The Surgical clinics of North America.
[31] G. Tytgat,et al. Impact of endoscopic biopsy surveillance of Barrett’s oesophagus on pathological stage and clinical outcome of Barrett’s carcinoma , 1998, Gut.
[32] Kenneth K Wang,et al. Updated Guidelines 2008 for the Diagnosis, Surveillance and Therapy of Barrett's Esophagus , 1998, The American Journal of Gastroenterology.
[33] V. Sharma,et al. Changing trends in esophageal cancer: a 15-year experience in a single center , 1998, American Journal of Gastroenterology.
[34] J. Miller,et al. Esophagectomy for cancer. , 1997, The Surgical clinics of North America.
[35] M. Helfand,et al. Risk factors for Barrett's esophagus in community-based practice. GORGE consortium. Gastroenterology Outcomes Research Group in Endoscopy. , 1997, The American journal of gastroenterology.
[36] J. Peters,et al. Outcome of adenocarcinoma arising in Barrett's esophagus in endoscopically surveyed and nonsurveyed patients. , 1994, The Journal of thoracic and cardiovascular surgery.
[37] F. Ellis,et al. Endoscopic surveillance of Barrett's esophagus. Does it help? , 1993, The Journal of thoracic and cardiovascular surgery.
[38] J. Fraumeni,et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. , 1991, JAMA.
[39] G Van Belle,et al. Observer variation in the diagnosis of dysplasia in Barrett's esophagus. , 1988, Human pathology.
[40] T. Hastie,et al. Does cancer risk affect health-related quality of life in patients with Barrett's esophagus? , 2007, Gastrointestinal endoscopy.
[41] C. D. Smith,et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device , 2005, Surgical Endoscopy And Other Interventional Techniques.
[42] P. Dítě,et al. [Barrett's esophagus]. , 2000, Bratislavske lekarske listy.
[43] Dawn Provenzale,et al. Barrett's esophagus: a new look at surveillance based on emerging estimates of cancer risk , 1999, American Journal of Gastroenterology.
[44] R. Sandler,et al. The relationship between gastroesophageal reflux disease and its complications with Barrett's esophagus. , 1997, The American journal of gastroenterology.